Naloxon B. Braun (Naloxone Hydrochloride)

Naloxone works as a competitive antagonist at mu‑opioid receptors. By binding more strongly than most opioid agonists, it displaces them from the receptor sites, stopping further opioid activity and quickly reversing respiratory depression and sedation.

The exact dose of Naloxon B. Braun is determined by the prescribing clinician based on the patient’s age, weight, severity of overdose, and clinical response. Typical adult regimens start with an initial 0.4‑2 mg IV or IM dose, but the prescriber sets the final regimen.

Safety data for naloxone in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use is generally reserved for life‑threatening situations, and the benefits of treating opioid toxicity usually outweigh potential risks.

To order Naloxon B. Braun, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Naloxon B. Braun contains naloxone, which has a rapid onset and short duration of action compared with longer‑acting antagonists such as naltrexone. This makes it ideal for emergency reversal of overdose, whereas other agents are more suited for maintenance therapy in opioid dependence.

Naloxon B. Braun must be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Naloxon B. Braun is administered by intramuscular or intravenous injection. The healthcare professional selects the route based on the clinical situation, injects the prescribed dose, and monitors the patient for reversal of opioid effects and any adverse reactions.

Serious risks include acute pulmonary edema, cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these rare but life‑threatening events occur after administration.

Naloxon B. Braun should not be used in patients with known hypersensitivity to naloxone or any component of the formulation. Caution is also advised in individuals with severe cardiovascular disease, as rapid reversal can precipitate abrupt changes in blood pressure.